Augmented Post-Induction Therapy for Children with High-Risk Acute Lymphoblastic Leukemia and a Slow Response to Initial Therapy, New England Journal of Medicine, vol.338, issue.23, pp.1663-71, 1998. ,
DOI : 10.1056/NEJM199806043382304
Intensive high-dose asparaginase consolidation improves survival for pediatric patients with T cell acute lymphoblastic leukemia and advanced stage lymphoblastic lymphoma: a Pediatric Oncology Group study, Leukemia, vol.13, issue.3, pp.335-377, 1999. ,
DOI : 10.1038/sj.leu.2401310
Improved outcome for children with acute lymphoblastic leukemia: results of Total Therapy Study XIIIB at St Jude Children's Research Hospital, Blood, vol.104, issue.9, pp.2690-2696, 2004. ,
DOI : 10.1182/blood-2004-04-1616
Superiority of Allogeneic Hematopoietic Stem-Cell Transplantation Compared With Chemotherapy Alone in High-Risk Childhood T-Cell Acute Lymphoblastic Leukemia: Results From ALL-BFM 90 and 95, Journal of Clinical Oncology, vol.24, issue.36, pp.5742-5751, 2006. ,
DOI : 10.1200/JCO.2006.06.2679
Significance of commonly used prognostic factors differs for children with T cell acute lymphocytic leukemia (ALL), as compared to those with B-precursor ALL. A Pediatric Oncology Group (POG) study, Leukemia, vol.13, issue.11, pp.1696-707, 1999. ,
DOI : 10.1038/sj.leu.2401555
The t(1;14)(p34;q11) is nonrandom and restricted to T-cell acute lymphoblastic leukemia: a Pediatric Oncology Group study, Blood, vol.76, pp.1220-1224, 1990. ,
The t(11;14)(p15;q11) in a T-cell acute lymphoblastic leukemia cell line activates multiple transcripts, including Ttg-1, a gene encoding a potential zinc finger protein., Molecular and Cellular Biology, vol.9, issue.5, pp.2124-2156, 1989. ,
DOI : 10.1128/MCB.9.5.2124
TTG-2, a new gene encoding a cysteine-rich protein with the LIM motif, is overexpressed in acute Tcell leukaemia with the t(11;14) (p13;q11), Oncogene, vol.6, pp.1887-93, 1991. ,
TAL2, a helix-loop-helix gene activated by the (7;9)(q34;q32) translocation in human T-cell leukemia., Proceedings of the National Academy of Sciences, vol.88, issue.24, pp.11416-11436, 1991. ,
DOI : 10.1073/pnas.88.24.11416
lyl-1, a novel gene altered by chromosomal translocation in T cell leukemia, codes for a protein with a helix-loop-helix DNA binding motif, Cell, vol.58, issue.1, pp.77-83, 1989. ,
DOI : 10.1016/0092-8674(89)90404-2
A new recurrent inversion, inv(7)(p15q34), leads to transcriptional activation of HOXA10 and HOXA11 in a subset of T-cell acute lymphoblastic leukemias, Leukemia, vol.19, issue.3, pp.358-66, 2005. ,
DOI : 10.1038/sj.leu.2403657
HOXA genes are included in genetic and biologic networks defining human acute T-cell leukemia (T-ALL), Blood, vol.106, issue.1, pp.274-86, 2005. ,
DOI : 10.1182/blood-2004-10-3900
Deregulation of a homeobox gene, HOX11, by the t(10;14) in T cell leukemia, Science, vol.253, issue.5015, pp.79-82, 1991. ,
DOI : 10.1126/science.1676542
A new recurrent and specific cryptic translocation, t(5;14)(q35;q32), is associated with expression of the Hox11L2 gene in T acute lymphoblastic leukemia, Leukemia, vol.15, issue.10, pp.1495-504, 2001. ,
DOI : 10.1038/sj.leu.2402249
TAN-1, the human homolog of the Drosophila Notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms, Cell, vol.66, issue.4, pp.649-61, 1991. ,
DOI : 10.1016/0092-8674(91)90111-B
Site-specific recombination of the tal-1 gene is a common occurrence in human T cell leukemia, EMBO J, vol.9, pp.3343-51, 1990. ,
Activating Mutations of NOTCH1 in Human T Cell Acute Lymphoblastic Leukemia, Science, vol.306, issue.5694, pp.269-71, 2004. ,
DOI : 10.1126/science.1102160
Activating NOTCH1 mutations predict favorable early treatment response and long-term outcome in childhood precursor T-cell lymphoblastic leukemia, Blood, vol.108, issue.4, pp.1151-1158, 2006. ,
DOI : 10.1182/blood-2005-12-4956
The t(10;11)(p13;q14) in the U937 cell line results in the fusion of the AF10 gene and CALM, encoding a new member of the AP-3 clathrin assembly protein family., Proceedings of the National Academy of Sciences, vol.93, issue.10, pp.4804-4813, 1996. ,
DOI : 10.1073/pnas.93.10.4804
HOX11L2-positive Tcell acute lymphoblastic leukemia. A collaborative study of the Groupe Francais de Cytogenetique Hématologique (GFCH) Groupe Français de Cytogénétique Hématologique (GFCH), Leukemia, vol.1417, issue.5, pp.1851-1858, 2003. ,
Fusion of NUP214 to ABL1 on amplified episomes in T-cell acute lymphoblastic leukemia, Nature Genetics, vol.9, issue.10, pp.1084-1093, 2004. ,
DOI : 10.1136/jmg.2003.016865
HOX11L2 expression defines a clinical subtype of pediatric T-ALL associated with poor prognosis, Blood, vol.100, issue.3, pp.991-998, 2002. ,
DOI : 10.1182/blood-2001-11-0093
Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia, Cancer Cell, vol.1, issue.1, pp.75-87, 2002. ,
DOI : 10.1016/S1535-6108(02)00018-1
Clinical significance of HOX11L2 expression linked to t(5;14)(q35;q32), of HOX11 expression, and of SIL-TAL fusion in childhood T-cell malignancies: results of EORTC studies 58881 and 58951, Blood, vol.103, issue.2, pp.442-50, 2004. ,
DOI : 10.1182/blood-2003-05-1495
The outcome of molecular-cytogenetic subgroups in pediatric T-cell acute lymphoblastic leukemia: a retrospective study of patients treated according to DCOG or COALL protocols, Haematologica, vol.91, pp.1212-1233, 2006. ,
Early response to therapy and outcome in childhood acute lymphoblastic leukemia, Cancer, vol.86, issue.9, pp.1717-1743, 1997. ,
DOI : 10.1002/(SICI)1097-0142(19971101)80:9<1717::AID-CNCR4>3.0.CO;2-B
Use of Recombinant Human Granulocyte Colony-Stimulating Factor to Increase Chemotherapy Dose-Intensity: A Randomized Trial in Very High-Risk Childhood Acute Lymphoblastic Leukemia, Journal of Clinical Oncology, vol.18, issue.7, pp.1517-1541, 2000. ,
DOI : 10.1200/JCO.2000.18.7.1517
Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL), Leukemia, vol.9, pp.1783-1789, 1995. ,
Standardization and quality control studies of ???real-time??? quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia ??? A Europe Against Cancer Program, Leukemia, vol.17, issue.12, pp.2318-57, 2003. ,
DOI : 10.1038/sj.leu.2403135
Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using ???real-time??? quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) ??? a Europe against cancer program, Leukemia, vol.17, issue.12, pp.2474-86, 2003. ,
DOI : 10.1038/sj.leu.2403136
CALM-AF10 is a common fusion transcript in T-ALL and is specific to the TCR???? lineage, Blood, vol.102, issue.3, pp.1000-1006, 2003. ,
DOI : 10.1182/blood-2002-09-2913
Various types of rearrangements targetTLX3 locus in T-cell acute lymphoblastic leukemia, Genes, Chromosomes and Cancer, vol.4, issue.3, pp.243-252, 2004. ,
DOI : 10.1002/gcc.20088
Predicts Adverse Outcome in Acute T-Lymphoblastic Leukemia in Adults, Journal of Clinical Oncology, vol.24, issue.29, pp.4714-4734, 2006. ,
DOI : 10.1200/JCO.2006.06.1580
Impact of TCR status and genotype on outcome in adult T-cell acute lymphoblastic leukemia: a LALA-94 study, Blood, vol.105, issue.8, pp.3072-3080, 2005. ,
DOI : 10.1182/blood-2004-09-3666
Tlx-1 and Tlx-3 homeobox gene expression in cranial sensory ganglia and hindbrain of the chick embryo: markers of patterned connectivity, J Neurosci, vol.18, pp.5389-402, 1998. ,
Promoter demethylation accompanies reactivation of theHOX11 proto-oncogene in leukemia, Genes, Chromosomes and Cancer, vol.234, issue.4, pp.371-378, 2000. ,
DOI : 10.1002/1098-2264(2000)9999:9999<::AID-GCC1050>3.0.CO;2-Y
Disruption of the RanBP17/Hox11L2 region by recombination with the TCR?? locus in acute lymphoblastic leukemias with t(5;14)(q34;q11), Leukemia, vol.16, issue.11, pp.2205-2217, 2002. ,
DOI : 10.1038/sj.leu.2402671
Transforming function of the HOX11/ TCL3 homeobox gene, Cancer Res, vol.57, pp.337-382, 1997. ,
HOX11 interacts with protein phosphatases PP2A and PP1 and disrupts a G2/M cell-cycle checkpoint, Nature, vol.385, issue.6615, pp.454-462, 1997. ,
DOI : 10.1038/385454a0
Prognostic importance of TLX1 (HOX11) oncogene expression in adults with T-cell acute lymphoblastic leukaemia, The Lancet, vol.363, issue.9408, pp.535-541, 2004. ,
DOI : 10.1016/S0140-6736(04)15542-6
Age-related phenotypic and oncogenic differences in T-cell acute lymphoblastic leukemias may reflect thymic atrophy, Blood, vol.104, issue.13, pp.4173-80, 2004. ,
DOI : 10.1182/blood-2003-11-3944
Long-term results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995, Leukemia, vol.14, issue.12, pp.2205-2227, 1981. ,
DOI : 10.1038/sj.leu.2401973
Long-term results of Total Therapy studies 11, 12 and 13A for childhood acute lymphoblastic leukemia at St Jude Children???s Research Hospital, Leukemia, vol.14, issue.12, pp.2286-94, 2000. ,
DOI : 10.1038/sj.leu.2401938
Genetic insights in the pathogenesis of T-cell acute lymphoblastic leukemia, Haematologica, vol.90, pp.1116-1143, 2005. ,
Prognostic and oncogenic relevance of TLX1/HOX11 expression level in T-ALLs, Blood, vol.110, issue.7, pp.2324-2354, 2007. ,
DOI : 10.1182/blood-2007-04-079988
MLL and CALM are fused to AF10 in morphologically distinct subsets of acute leukemia with translocation t(10;11): both rearrangements are associated with a poor prognosis, Blood, vol.91, pp.4662-4669, 1998. ,